{{Rsnum
|rsid=10519262
|Chromosome=15
|position=50140297
|Orientation=plus
|GMAF=0.2424
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.6 | 44.6 | 51.8
| HCB | 14.6 | 51.1 | 34.3
| JPT | 18.6 | 47.8 | 33.6
| YRI | 0.0 | 10.9 | 89.1
| ASW | 0.0 | 8.8 | 91.2
| CHB | 14.6 | 51.1 | 34.3
| CHD | 24.8 | 42.2 | 33.0
| GIH | 9.9 | 49.5 | 40.6
| LWK | 0.0 | 4.5 | 95.5
| MEX | 6.9 | 39.7 | 53.4
| MKK | 1.9 | 16.7 | 81.4
| TSI | 6.9 | 45.1 | 48.0
| HapMapRevision=28
}}[[rs10519262]], a intergenic SNP on chromosome 15, is reported to influence the risk for [[Alzheimer's disease]] based on a study of ~1100 Canadian patients. The risk allele is (A); the odds ratio is 1.89 (CI: 1.46 - 2.45). {{PMID|17998437}}

{{PMID Auto
|PMID=19204163
|Title=GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results.
|OA=1
}}

{{PMID Auto
|PMID=17999355
|Title=A genomewide association study of skin pigmentation in a South Asian population.
|OA=1
}}

{{PMID Auto
|PMID=19640594
|Title=Recent insights into the molecular genetics of dementia.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}